On May 13, 2025, Zhang Guofeng, Secretary of the Jiangbei District Committee, visited Tianyuan Biotechnology Co., Ltd. for research and in-depth understanding of the company's development situation. Huang Bisheng, Chairman of the company, and Zhu Youwu, Group Chief Executive Officer, warmly received and accompanied the entire process.

     At Tianyuan Biotechnology Co., Ltd., Secretary Zhang Guofeng first visited the company's life technology exhibition hall and laboratory, gaining a preliminary understanding of Tianyuan Biotechnology's diversified layout in the field of full lifecycle health management. As an important part of the Biomedical Research Institute of Ningbo University, the company has always adhered to the mission of "integrating the essence of science and protecting human health", focused on the forefront of life science and technology, continued to make efforts in technology innovation, product research and development, and committed to providing high-quality products and services for the national health cause.

     It is worth mentioning that Tianyuan Biotechnology is the only enterprise in China that has built an HLA typing library, and is the only storage institution in the Metabolic Immunology Laboratory of the National Health Commission. At the same time, the company also has advanced iPS cell research capabilities and has made significant progress in cutting-edge fields such as cell therapy. These unique research advantages have enabled Tianyuan Biotechnology to occupy an important position in the biopharmaceutical industry.

     During the research process, Secretary Zhang Guofeng highly praised the development of Tianyuan Biotechnology Co., Ltd. He pointed out that Tianyuan Biotechnology, as a leader in the field of biomedicine in Ningbo, fully demonstrates the innovative vitality and development potential of the enterprise. The company's outstanding scientific research achievements in the city and even nationwide are inseparable from its strong scientific research strength, clear development strategy, and persistent pursuit of technological innovation. Secretary Zhang emphasized that technological innovation is the core driving force for enterprise development, and Tianyuan Biotechnology's continuous investment and achievements in scientific research reflect the company's foresight and responsibility. Especially in the context of the "Healthy China 2030 Plan Outline", Tianyuan Biotechnology's research direction is highly aligned with the national development strategy, and has made important contributions to promoting the construction of a Healthy China.

     Chairman Huang Bisheng stated that Secretary Zhang Guofeng's visit for research is not only an encouragement and impetus for Tianyuan Biotechnology, but also points out the direction for the future development of the enterprise. Tianyuan Biotechnology will live up to expectations, continue to deepen its cultivation in the field of life science and technology with more enthusiasm and firm confidence, promote high-quality development of the enterprise, and contribute more to the economic and social development of Jiangbei District.

Deputy District Chief Xie Jun and others accompanied the research.